EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
50 hedge funds and large institutions have $86.6M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.69M | |
| 2 | +$3.34M | |
| 3 | +$2.84M | |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$2.27M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$1.31M |
Top Sellers
| 1 | -$2.94M | |
| 2 | -$1.98K | |
| 3 | -$198 | |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$10 |